Protection against Amoebic Liver Abscess in Hamster by Intramuscular Immunization with anAutographa californicaBaculovirus Driving the Expression of the Gal-Lectin LC3 Fragment
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Protection against Amoebic Liver Abscess in Hamster by Intramuscular Immunization with anAutographa californicaBaculovirus Driving the Expression of the Gal-Lectin LC3 Fragment
Authors
Keywords
-
Journal
Biomed Research International
Volume 2015, Issue -, Pages 1-10
Publisher
Hindawi Limited
Online
2015-05-20
DOI
10.1155/2015/760598
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The future for vaccine development against Entamoeba histolytica
- (2014) Jeanie Quach et al. Human Vaccines & Immunotherapeutics
- Baculovirus: an Insect-derived Vector for Diverse Gene Transfer Applications
- (2013) Kari J Airenne et al. MOLECULAR THERAPY
- Oral lactoferrin treatment resolves amoebic intracecal infection in C3H/HeJ mice1This article is part of a Special Issue entitled Lactoferrin and has undergone the Journal’s usual peer review process.
- (2012) Nidia León-Sicairos et al. Biochemistry and Cell Biology
- Mucosal Delivery of ACNPV Baculovirus Driving Expression of the Gal-Lectin LC3 Fragment Confers Protection against Amoebic Liver Abscess in Hamster
- (2012) DM Meneses-Ruiz et al. International Journal of Biological Sciences
- Efficacy of a Gal-lectin subunit vaccine against experimental Entamoeba histolytica infection and colitis in baboons (Papio sp.)
- (2012) Mohamed D. Abd Alla et al. VACCINE
- Baculovirus as a vaccine vector
- (2012) Hsin-Yu Lu et al. Bioengineered
- Baculovirus as vectors for human cells and applications in organ transplantation
- (2011) Richard B Hitchman et al. JOURNAL OF INVERTEBRATE PATHOLOGY
- Baculoviruses as gene therapy vectors for human prostate cancer
- (2011) Guillermo C. Rivera-Gonzalez et al. JOURNAL OF INVERTEBRATE PATHOLOGY
- Non-human viruses developed as therapeutic agent for use in humans
- (2011) Danijela Koppers-Lalic et al. REVIEWS IN MEDICAL VIROLOGY
- Host Innate Immune Responses Induced by Baculovirus in Mammals
- (2010) Takayuki Abe et al. CURRENT GENE THERAPY
- Protection against murine intestinal amoebiasis induced by oral immunization with the 29kDa antigen of Entamoeba histolytica and cholera toxin
- (2010) J.C. Carrero et al. EXPERIMENTAL PARASITOLOGY
- Gastrointestinal Delivery of Baculovirus Displaying Influenza Virus Hemagglutinin Protects Mice against Heterologous H5N1 Infection
- (2010) M. Prabakaran et al. JOURNAL OF VIROLOGY
- Recombinant Baculovirus as a Highly Potent Vector for Gene Therapy of Human Colorectal Carcinoma: Molecular Cloning, Expression, and In Vitro Characterization
- (2010) Arghya Paul et al. MOLECULAR BIOTECHNOLOGY
- Intranasal and intramuscular immunization with Baculovirus Dual Expression System-based Pvs25 vaccine substantially blocks Plasmodium vivax transmission
- (2010) Andrew M. Blagborough et al. VACCINE
- CD4+ and CD8+ T cell- and IL-17-mediated protection against Entamoeba histolytica induced by a recombinant vaccine
- (2010) Xiaoti Guo et al. VACCINE
- Recent discoveries in the pathogenesis and immune response towardEntamoeba histolytica
- (2009) Manigandan Lejeune et al. Future Microbiology
- Protection against Intestinal Amebiasis by a Recombinant Vaccine Is Transferable by T Cells and Mediated by Gamma Interferon
- (2009) X. Guo et al. INFECTION AND IMMUNITY
- Baculovirus-Based Nasal Drop Vaccine Confers Complete Protection against Malaria by Natural Boosting of Vaccine-Induced Antibodies in Mice
- (2009) S. Yoshida et al. INFECTION AND IMMUNITY
- A Baculovirus Dual Expression System-Based Malaria Vaccine Induces Strong Protection against Plasmodium berghei Sporozoite Challenge in Mice
- (2009) S. Yoshida et al. INFECTION AND IMMUNITY
- A pseudotype baculovirus-mediated vaccine confers protective immunity against lethal challenge with H5N1 avian influenza virus in mice and chickens
- (2009) Qunfeng Wu et al. MOLECULAR IMMUNOLOGY
- A pcDNA-Ehcpadh vaccine against Entamoeba histolytica elicits a protective Th1-like response in hamster liver
- (2009) Máximo B. Martínez et al. VACCINE
- Natural Killer T Cells Activated by a Lipopeptidophosphoglycan from Entamoeba histolytica Are Critically Important To Control Amebic Liver Abscess
- (2009) Hannelore Lotter et al. PLoS Pathogens
- Persistence of Entamoeba histolytica infection in CBA mice owes to intestinal IL-4 production and inhibition of protective IFN-γ
- (2008) X Guo et al. Mucosal Immunology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started